Medicare Covers GLP-1s Starting July 2026: Your Step-by-Step Prescription Guide

For the first time in over 20 years, Medicare will cover prescription medications specifically for weight loss. The Medicare GLP-1 Bridge is a nationwide pilot program launching July 1, 2026, offering eligible Part D beneficiaries access to FDA-approved GLP-1 medications at a flat $50 monthly copay.

This guide walks you through every step — from confirming eligibility to filling your first prescription at the pharmacy.

What's Covered

The Bridge covers three FDA-approved weight loss medications: Wegovy (semaglutide) in both injectable and oral tablet form, the KwikPen formulation of Zepbound (tirzepatide), and Foundayo. These are brand-name products only — compounded semaglutide and tirzepatide are not covered.

Eligibility Criteria

To qualify, you must meet all of the following:

1. Enrolled in a Medicare Part D plan — this is the prescription drug coverage portion of Medicare
2. BMI ≥ 35 at the time GLP-1 therapy was initiated, OR BMI ≥ 27 with at least one qualifying weight-related condition (heart disease, type 2 diabetes, hypertension, high cholesterol, obstructive sleep apnea, or prediabetes)
3. Prescribed by a licensed provider who submits a prior authorization attesting you meet the clinical criteria

If you're already on a GLP-1 and your BMI has since dropped below the threshold, you still qualify — your provider attests to your BMI at the time therapy was started, not your current BMI.

Step-by-Step: How to Get Your Prescription

Step 1: Confirm Part D Enrollment (Now)

Check that you have active Medicare Part D coverage. If you don't, you'll need to enroll during the next available enrollment period or qualify for a Special Enrollment Period.

Step 2: Schedule a Provider Appointment (May–June)

Talk to your doctor about GLP-1 eligibility. They'll need to document your BMI history, qualifying conditions, and treatment rationale. Don't wait until July — start the conversation now so paperwork is ready.

Step 3: Prior Authorization Submission (Your Provider Does This)

Your prescriber submits a prior authorization to a CMS-contracted central processor — not your Part D insurance plan. This is a separate pathway from normal Part D claims. Your provider must attest that you meet the BMI and medical criteria.

Step 4: Fill Your Prescription (Any Pharmacy)

Pharmacies don't need to opt in. Take your prescription to any pharmacy, present your Medicare Part D card, and pay the $50 copay. The pharmacy submits the claim to the central processor for reimbursement.

Step 5: Monthly Refills

The $50 copay stays flat every month, regardless of which Part D benefit phase you're in. No deductible applies. Continue refilling monthly through the program's duration (through December 31, 2027).

Important Limitations

• The $50 copay does not count toward your Part D deductible or the $2,100 out-of-pocket cap
• Low-income subsidy (Extra Help) benefits do not apply to Bridge program copays
• Only brand-name FDA-approved medications are covered — no compounded formulations
• The program is temporary — extended through December 31, 2027, with future coverage dependent on BALANCE Model implementation
• Ozempic and Mounjaro are not covered under the Bridge (they're approved for diabetes, not weight loss)

What Happens After 2027?

The Bridge was designed as a temporary measure while CMS implements the longer-term BALANCE Model. The BALANCE Model for Medicare Part D was originally planned for January 2027 but has been delayed. CMS extended the Bridge through 2027 to maintain uninterrupted access. What happens in 2028 and beyond remains uncertain — monitor CMS announcements during Medicare Open Enrollment (October 15–December 7, 2026) for updates.